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A B ST R AC T  
 
Aim: Hepatosteatosis confers increased lipid accumulation in the hepatocytes which is associated 
with inflammation. Hemogram parameters, such as mean platelet volume (MPV) and MPV to platelet 
ratio (MPR) are proposed as novel inflammatory markers in recent studies. We aimed to compare 
MPR of subjects with hepatosteatosis to those in healthy controls. 
Methods: Patient admissions to our clinic with a diagnosis of hepatosteatosis were retrospectively 
analyzed MPR values compared to those in healthy controls.  
Results: Mean MPR of hepatosteatosis group (0,04 ± 0,01fL/mm3) was significantly higher than the 
MPR of control subjects (0,03 ± 0,01 fL/mm3) (p=0.04). A Pearson’s Correlation analyze was 
revealed significant correlations between MPR and fasting plasma glucose (r=0.26, p=0.004) and 
between MPR and LDL-cholesterol (r=0.19, p=0.04). 
Conclusion: An elevated MPR should alert physicians for hepatosteatosis in otherwise healthy 
subjects. Therefore, calculation of MPR by automatic hemogram analyzers is advised. 
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Introduction 
Hepatosteatosis confers increased lipid 
accumulation in the hepatocytes. It is one of 
the clinical spectrums of nonalcoholic fatty 
liver disease. Despite it is the mildest form of 
NAFLD, it may progress to steatohepatitis, 
fibrosis and cirrhosis [1]. Inflammation is 
involved in the course of hepatosteatosis.  An 
inflammatory marker, interleukin-6, have been 
proposed to be linked to steatosis [2].  
Hemogram parameters are proposed as novel 
inflammatory markers in recent studies. These 
parameters include mean platelet volume 
(MPV), red cell distribution width (RDW) and 
neutrophil to lymphocyte ratio (NLR), which 
all have shown to be associated with 
inflammatory conditions [3-7]. A novel 
hemogram derived indices, MPV to platelet 
ratio (MPR), have been found to be associated 
with various inflammatory conditions [8-10].  
In present retrospective analysis, we aimed to 
compare MPR of subjects with hepatosteatosis 
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to those in healthy controls and find out 
whether it was associated with serum lipids 
and glucose levels.  
 
Methods 
Patient admissions to our clinic with a 
diagnosis of hepatosteatosis were 
retrospectively analyzed between, January 
2015 and December 2017. Diagnosis of 
hepatosteatosis was established by 
sonography. Control subjects were enrolled to 
the study from healthy volunteers whom 
presented to our clinic for a routine check-up. 
Data of the subjects obtained from 
computerized database of the institution and 
patients’ files. Subjects with malignant 
diseases, active infection or inflammatory 
conditions were excluded.  
Age, gender, and laboratory parameters, such 
as, aspartate transaminase, alanine 
transaminase, fasting plasma glucose, serum 
creatinine, serum lipids (LDL cholesterol and 
triglyceride), and hemogram parameters 
including white blood cell count (WBC), 
hemoglobin (Hb), hematocrit (Htc), platelet 
count (Plt) and MPV were recorded. A MPR 
value is calculated by simply dividing of MPV 
by Plt.  
Statistical analysis were done with SPSS 
software (SPSS 15.0 for Windows, IBM Corp., 
Chicago, IL, USA). Study variables conducted 
with Kolmogorov- Smirnov test for 
distribution between study and control groups. 
While comparison of homogenously 
distributed parameters were done with 
independent samples t test and expressed as 
mean ± standard deviation, comparison of 
nonhomogeneous parameters were conducted 
with Mann Whitney U test and expressed as 
median (minimum-maximum). P values lower 
than 0.005 were considered statistically 
significant.  
Results 
A total of 119 subjects enrolled to the study; 61 
in hepatosteatosis group and 58 in control 
group. Mean age of hepatosteatosis and control 
groups were 47 ± 12 years and 43,5 ± 10 years, 
respectively. Age was not statistically different 
between groups (p=0.08). There were 29 
women and 32 men in hepatosteatosis group 
and 23 women and 35 men in control group. 
Gender was not statistically different among 
study groups, either (p=0.39).  
Serum creatinine (p=0.23), WBC (p=0.47), Hb 
(p=0.48), Htc (p=0.85), and Plt (p=0.06) were 
not significantly different in hepatosteatosis 
group compared to control group. Fasting 
plasma glucose, triglyceride, LDL cholesterol, 
AST, ALT and MPV were significantly 
different between study groups (p<0.05 for 
all). Mean MPR of hepatosteatosis group (0,04 
± 0,01 fL/mm3) was significantly higher than 
the MPR of control subjects (0,03 ± 0,01 
fL/mm3) (p=0.04). Table 1 shows data of the 
study subjects.  
A Pearson’s Correlation analyze was revealed 
significant correlations between MPR and 
fasting plasma glucose (r=0.26, p=0.004) and 
between MPR and LDL-cholesterol (r=0.19, 
p=0.04).  
 
Discussion 
Present study showed that hepatosteatosis is 
significantly associated with elevated levels of 
MPR, due to increased inflammatory burden. 
Another important result of the present report 
is that MPR was significantly and positively 
correlated with fasting plasma glucose and 
LDL-cholesterol.  
Recent studies focused on the association 
between MPR and several clinical conditions, 
ie, cancer, ischemic heart disease and 
infections. Azab et al reported that MPR was 
an   independent    predictor   of   mortality   in  
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patients with non ST elevation myocardial 
infarction [9]. Another study found 
significantly increased MPR levels in subjects 
with hepatocellular carcinoma compared to 
controls [10]. Authors also showed increased 
MPR in patients with infective endocarditis 
[11]. 
Hepatic steatosis is the initial clinical picture 
of NAFLD. It is characterized with increased 
lipid accumulation in hepatocytes. Steatosis in 
the liver make susceptible to the attack of 
inflammatory cytokines, such as, tumor 
necrosis factor-alpha, transforming growth 
factor-beta and interleukins [1]. Elevated MPR 
in subjects with hepatosteatosis detected in 
present study could be explained by is the 
associations    between   hepatosteatosis     and    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
inflammation and between MPR and 
inflammatory conditions. 
Diseases characterized with low grade 
inflammation are associated with elevated 
MPV values [12]. Since type 2 diabetes 
mellitus and obesity produce a continuous and 
low grade inflammatory burden, they are all 
related increased levels of MPV [13, 14]. 
Moreover, hepatic steatosis is prevalent in 
obesity and type 2 diabetes mellitus [1]. 
Correlation between plasma glucose and MPR 
in present study suggests the previous findings 
of the studies in literature. In addition, elevated 
MPV has been reported in hepatosteatosis, too 
[15]. Since MPV is numerator and Plt is 
denominator in calculation of MPR, elevation 
in MPV increases MPR values.  
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Despite high MPV values are indicative of 
platelet activation [12], MPR is better than 
MPV in predicting platelet activity [16]. This 
fact has been suggested by Han et al, whom 
reported greater sensitivity and specifity of 
PMR compared to MPV in detecting 
thrombosis [17].   
Limitations of present study are retrospective 
design and relatively small study cohort. 
However, results of the present report are 
important, since, to our knowledge, this is the 
first study pointed out the elevated MPR in 
hepatosteatosis. 
In conclusion, an elevated MPR should alert 
physicians for hepatosteatosis in otherwise 
healthy subjects. Therefore, calculation of 
MPR by automatic hemogram analyzers is 
advised.  
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